Both in Surgical Instruments
Nephros vs Xtant Medical Holdings
Over the past year NEPH returned −37.5% and XTNT returned −60.1%; their daily moves had a correlation of 0.05.
NEPH −37.5% XTNT −60.1%Growth of $1, one year, split-adjusted
| Metric | NEPH | XTNT |
|---|---|---|
| Price | $3.25 | $0.2960 |
| Market cap | $35.3M | $41.5M |
| Today | +0.31% | +6.47% |
| 1 month | +7.6% | −7.7% |
| 6 months | +0.9% | −48.7% |
| Year to date | −33.4% | −62.2% |
| 1 year | −39.5% | −63.5% |
| Revenue growth (YoY) | +36.2% | −35.0% |
| Gross margin | 66.9% | 57.9% |
| Net margin | 19.9% | −40.9% |
| P/E (TTM) | 20.3× | — |
| Price / sales | 1.7× | 0.4× |
| Net cash | $4.7M | -$13.2M |
| Dividend yield | — | — |
| Volatility (60d) | 72.5% | 69.4% |
| Short % of float | 0.2% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).